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Abstract 23 
A number of different forms of protein and their analogues have been investigated for their 24 
efficacy in ameliorating exercise-induced muscle damage (EIMD) and recovery. Preliminary 25 
data regarding whey protein hydrolysate (WPH) supplementation are promising. However, its 26 
efficacy beyond acute eccentric/resistance exercise bouts or longer-term training programmes 27 
are limited and all investigations have been conducted in male or mixed-sex groups. This 28 
study sought to elucidate whether the benefits of WPH previously reported can be 29 
demonstrated in females following repeated-sprint exercise. Twenty physically active 30 
females were assigned to consume two doses of 70 ml WPH or isoenergetic carbohydrate 31 
(CHO) for 4 days post EIMD. Measures of muscle soreness, limb girth, flexibility, muscle 32 
function and creatine kinase were collected pre, immediately post, and 24, 48 and 72 h post-33 
exercise. Time effects were observed for all variables (p < 0.05) except limb girth; indicative 34 
of EIMD. Flexibility improved beyond baseline measures following WPH by 72 h, but had 35 
failed to recover in the CHO group (p = 0.011). Reactive strength index was higher 36 
throughout recovery in the WPH group compared to CHO (p = 0.016). Reductions in creatine 37 
kinase were greater following WPH compared to CHO at 48 h post EIMD (p = 0.031). The 38 
findings suggest that four day supplementation of WPH is beneficial for reducing symptoms 39 
of EIMD and improving recovery of muscle function in physically active females.  40 





Exercise has been shown to increase protein turnover and amino acid oxidation (Evans, 1991) 45 
and this might be exacerbated in exercise-induced muscle damage (EIMD) paradigms given 46 
the structural damage to skeletal muscle that might occur. Indeed, rates of muscle protein 47 
synthesis (MPS) and muscle protein breakdown (MPB) are increased following 48 
unaccustomed, muscle-damaging exercise, and while this has been suggested to be unrelated 49 
to the muscle contraction performed (Phillips, Tipton, Aarsland, Wolf, & Wolfe, 1997), 50 
others suggest that MPS are greater following eccentric compared to concentric contractions 51 
(Eliasson et al., 2006; Moore, Phillips, Babraj, Smith, & Rennie, 2005); perhaps mediated 52 
through a combination of greater tension and stretching of the muscle (Eliasson et al., 2006). 53 
However, at least in the fasted state there is a negative net muscle protein balance which does 54 
not become positive post-exercise if not compensated for through protein availability 55 
(Kumar, Atherton, Smith, & Rennie, 2009; Phillips et al., 1997; Pitkanen et al., 2003). 56 
Consequently, protein intake might provide the required amino acids necessary for improving 57 
protein balance, which is crucial for repairing damaged structural proteins (Saunders, 2007; 58 
Tipton, 2008), and thus attenuating the negative symptoms associated with muscle damage. 59 
Of contemporary interest is supplementation with hydrolysed proteins. These supplements 60 
are pre-digested proteins that are partially broken-down when exposed to heat, enzymes, or 61 
acids; producing large quantities of shorter chain peptides. As such, it is recognised that 62 
protein hydrolysates are more readily digested and absorbed, and increase circulating amino 63 
acid concentrations more rapidly than ‘intact’ proteins (Koopman et al., 2009; Manninen, 64 
2004; Morifuji et al., 2010; Silk et al., 1979). Recently, the efficacy of whey protein 65 
hydrolysate (WPH) supplementation on reducing markers of muscle damage and accelerating 66 
recovery has received attention in the literature. The evidence for WPH in combination with 67 
carbohydrate are encouraging; with reported decreases in systemic indices of muscle damage 68 
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(Hansen, Bangsbo, Jensen, Bibby, & Madsen, 2015; Lollo et al., 2014), increases in satellite 69 
cell proliferation (Farup et al., 2014), alterations in signalling associated with muscle protein 70 
turnover (Rahbek, Farup, de Paoli, & Vissing, 2015), and accelerated physical (Cooke, 71 
Rybalka, Stathis, Cribb, & Hayes, 2010; Hansen et al., 2015) and psychological (Hansen et 72 
al., 2015) recovery. Data also appear to suggest that when consumed in isolation, there is 73 
greater benefit of WPH over other forms of whey to reduce symptoms of EIMD with both 74 
acute (Buckley et al., 2010) and more long-term (Lollo et al., 2014) supplementation 75 
strategies.  76 
Preliminary data regarding WPH supplementation are promising, however, presently, no 77 
study has examined effects following an acute bout of repeated-sprint exercise and all 78 
investigations exploring the influence of WPH on EIMD and recovery have been conducted 79 
with male or mixed sex groups (Buckley et al., 2010; Cooke et al., 2010; Farup et al., 2014; 80 
Hansen et al., 2015; Lollo et al., 2014; Rahbek et al., 2015). Although there have been no 81 
reported sex differences in the basal and post-exercise rates of MPS and MPB (Fujita, 82 
Rasmussen, Bell, Cadenas, & Volpi, 2007; Miller et al., 2006), the literature examining the 83 
differences in the susceptibility to EIMD between men and women remains equivocal 84 
(Dannecker et al., 2012; Enns & Tiidus, 2010). Certainly, more research in females is 85 
warranted, and female exercisers would benefit from a practical nutritional intervention to 86 
improve recovery; from a single bout of exercise, and during intensified training periods, 87 
where recovery times may be limited. Therefore, the aim of this investigation was to examine 88 
the efficacy of WPH gel supplementation on physiological and functional recovery following 89 
a bout of exercise designed to cause temporary muscle damage in females. It was 90 
hypothesised that indices of EIMD would be attenuated by the consumption of the WPH gel.  91 
 92 
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Materials and methods 93 
Participants 94 
Twenty physically active females (mean ± SD age 20 ± 1 y; stature 165.9 ± 5.6 cm; body 95 
mass 61.8 ± 7.9 kg) from a university dance team volunteered to participate and provided 96 
written informed consent. Participants were required to complete a menstrual cycle 97 
questionnaire, which identified the contraceptive use of participants; eight were using an oral 98 
combination pill (all monophasic), six were using a progesterone only pill/implant/injection, 99 
and six were normally menstruating.  All testing took place during the early/mid luteal phase 100 
or where applicable in the 14 days prior to a withdrawal bleed. For 24 h prior to, and 101 
throughout the testing period, participants were required to refrain from strenuous exercise, 102 
and any anti-inflammatory drugs or alternative treatments, and dietary intake was controlled. 103 
The study received ethical approval from the Faculty of Health and Life Sciences Ethics 104 
Committee at the University of Northumbria. 105 
Experimental protocol 106 
Using a randomised, double-blind design, participants were allocated to a whey protein 107 
hydrolysate group (WPH) or an isoenergetic carbohydrate group (CHO) and these groups 108 
were matched and counterbalanced for muscle function (maximum voluntary isometric 109 
contraction). Participants were provided with standardised meals 24 h prior to initial testing 110 
and were fasted for ≥10 h except for water, which was consumed ad libitum. On arrival at the 111 
laboratory, baseline measures of dependent variables were recorded and participants 112 
subsequently completed the exercise protocol designed to induce muscle damage. After a 2 113 
min rest, participants consumed a dose of the WPH or CHO supplement within 10 min and 114 
baseline measures were repeated. Participants consumed a standardised breakfast meal and a 115 
supplement was provided to be consumed 2 h post-exercise. Baseline measures were then 116 
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repeated following an overnight fast at the same time of day (± 1 h to account for diurnal 117 
variation) for the following 3 days after the exercise; 24, 48, and 72 h post damaging 118 
exercise. During this time, all food was provided and participants were required to consume 119 
two bolus 20 g doses of WPH or CHO each day. Please refer to Figure 1 for an illustration of 120 
the study design. 121 
Dietary control 122 
Food intake was controlled throughout all trial periods; breakfast, lunch, evening meals as 123 
well as regular snacks were provided (please refer to Table 1 for an example of the food 124 
provided each day). This ensured that sufficient amounts of carbohydrate (5-7 g·kg-1·day-1) 125 
(Burke, Loucks, & Broad, 2006) and protein (1.2-1.7 g·kg-1·day-1) (Tipton & Wolfe, 2004) 126 
recommended for athletic populations were met by all participants (Table 2). In addition, 127 
quantities of carbohydrate thought to saturate muscle glycogen resynthesis (1-1.2 g·kg-1) and 128 
quantities of protein thought to support MPS (0.25-0.3 g·kg-1) (Thomas, Erdman, & Burke, 129 
2016) were consumed within 45-60 min of exercise. No changes in body mass were observed 130 
between the initial testing day (day 1; 64.8 ± 7.5 kg and 58.7 ± 7.3 kg for WPH and CHO, 131 
respectively) and the final testing day (day 4; 65.1 ± 7.1 kg and 58.9 ± 7.6 kg for WPH and 132 
CHO, respectively) in both treatment groups (both p > 0.05), demonstrating that participants 133 
were likely in energy balance.  134 
Supplementation 135 
The nutritional composition of the supplements is presented in Table 3. Post EIMD, 136 
participants consumed a daily dose of two 20g bolus amounts of the WPH or CHO in gel 137 
form. On the day of muscle-damaging exercise, these doses were consumed immediately post 138 
and 2 h post-exercise. For the following two days, these doses were consumed 30-60 min 139 
prior to subsequent morning visits and prior to their evening meal, and a final supplement 140 
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was consumed prior to final measurements at 72 h post-exercise. This is based on recent 141 
work demonstrating an effect when WPH is consumed for three days following EIMD (Farup 142 
et al., 2014; Rahbek et al., 2015). Both WPH and CHO gels were lemon flavoured, 143 
isovolumetric and isocaloric, and were microbiologically screened and Informed Sport tested. 144 
Supplements were provided in identical packaging (Science in Sport Ltd, Farringdon, 145 
London) and subsequently labelled in a double-blind manner.  146 
Exercise protocol 147 
Prior to baseline measurement of muscle function and prior to exercise, participants 148 
completed a standardised warm up (Glaister, Howatson, Abraham, et al., 2008; Glaister et al., 149 
2007; Glaister, Howatson, Pattison, & McInnes, 2008). Participants were also given 5 min to 150 
perform any personal stretches and prepare themselves for measurement of muscle function 151 
and the exercise protocol.  152 
Participants completed a repeated-sprint protocol described previously (Howatson & Milak, 153 
2009). This comprises 15 x 30 m sprints (each separated by 60 s rest) with a rapid 10 m 154 
deceleration phase. This damage model has been demonstrated to induce muscle damage 155 
previously (Howatson & Milak, 2009; Keane, Salicki, Goodall, Thomas, & Howatson, 2015). 156 
Rate of perceived exertion (RPE; (Borg, 1982)) and heart rate (HR; Model RS-400, Polar, 157 
Kempele, Finland) were collected after each sprint effort. The 15 x 30 m sprint times were 158 
also recorded to determine total sprint time, mean sprint time, and rate of fatigue using the 159 
following formula (Fitzsimons, Dawson, Ward, & Wilkinson, 1993):  160 
Fatigue index (%) = (100 x [total sprint time/ideal sprint time]) - 100, in which total sprint 161 
time = sum of sprint times from all sprints, and ideal sprint time = the number of sprints x 162 
fastest sprint time. 163 
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Dependant variables 164 
Muscle soreness 165 
Subjective delayed onset of muscle soreness (DOMS) was measured using a 200 mm visual 166 
analogue scale with ‘no soreness’ and ‘unbearably sore’ anchored at each end of the scale. 167 
On each occasion, participants were required to complete a 900 squat with hands on their 168 
hips, and upon standing, to indicate on the line the level of perceived active lower limb 169 
soreness felt. Pain pressure threshold (PPT) was measured with a digital algometer with a 170 
connecting 1.0 cm2 flat, circular rubber disc (Model FDX, Wagner Instruments, Greenwich, 171 
USA). Three muscle locations were determined; the rectus femoris (RF), the vastus lateralis 172 
(VL), and medial head of the gastrocnemius (GM) (Clifford, Bell, West, Howatson, & 173 
Stevenson, 2016). All measurements were taken on the right side of the participant and were 174 
marked with permanent marker to ensure accuracy on consecutive days (Vatine, Shapira, 175 
Magora, Adler, & Magora, 1993). To determine PPT, participants were asked to verbally 176 
indicate when the pressure applied to the muscle while supine (at an approximate rate of 5 177 
N·s-1) became uncomfortable. Intra-trial and inter-trial percentage coefficient of variation 178 
(%CV) was < 8% for all locations. 179 
Limb girth 180 
Limb girth was measured as an indirect marker of inflammatory swelling and oedema (Smith, 181 
1991; van Someren, Edwards, & Howatson, 2005). An anthropometric tape measure 182 
(Bodycare Products, Warwickshire, United Kingdom) was used to determine girths at the calf 183 
(measured at its largest girth at baseline) and mid-thigh (located as midway between the 184 
inguinal fold and the superior border of the patella) of the right leg. These locations on the 185 
skin were marked with permanent marker on the initial day of testing to ensure consistency in 186 
measurement on subsequent days. Calf and mid-thigh girth intra-examiner %CVs were < 1%. 187 
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Hamstring stiffness and flexibility 188 
The sit and reach test was used to measure hamstring stiffness and flexibility. Participants 189 
were required to sit with their knees fully extended and feet together against the sit and reach 190 
box; the heel position in line with the 15 cm position on the box. With one hand placed over 191 
the other, participants were instructed to slowly reach forward along the measuring board to 192 
avoid rapid or forceful movements. They were asked to stretch as far as possible (but not to 193 
the point of pain) and to hold their ‘best stretch’ for approximately 2 s (American College of 194 
Sports Medicine, 2013). The score of this final position was recorded to the nearest 0.5 cm. 195 
Intra-trial and inter-trial %CV was < 5%. 196 
Muscle function 197 
Participants completed three countermovement jumps (CMJ) and three drop jumps (for 198 
measurement of reactive strength index (RSI)) using a light timing system (Optojump, 199 
Microgate, Bolzano, Italy), keeping their hands on their hips throughout. For CMJ, 200 
participants were asked to squat down (bending at the knee, hip and ankle while keeping their 201 
heels on the floor and their back straight) with their feet shoulder width apart and to jump 202 
vertically and maximally. For RSI (the jump height (cm) ÷ contact time (s) of each drop 203 
jump), participants were asked to drop from a 30 cm box and upon landing to perform a two-204 
footed jump maximally with minimum contact time. Legs were kept straight while jumping; 205 
only bending once the feet contacted the ground. Each jump effort was separated by 60 s of 206 
rest, and the peak CMJ and RSI was used for analysis. Intra-trial and inter-trial %CV was 207 
both < 4% and < 12% for CMJ and RSI respectively. 208 
Maximum voluntary isometric contraction (MVC) of the right knee extensors was measured 209 
using a strain gauge (MIE Digital Myometer, MIE Medical Research Ltd, Leeds, UK). While 210 
in a seated position, the strain gauge load cell was wrapped immediately above the malleoli 211 
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(a layer of padding was in place to avoid participant discomfort) and attached securely to a 212 
plinth on a purpose-built chair at the same height. The knee joint angle was standardised at 213 
900 of flexion using a goniometer and confirmed before each contraction. Participants 214 
received a verbal countdown of 3 s before extending their knee ‘as fast and as hard as 215 
possible’ (Sahaly, Vandewalle, Driss, & Monod, 2001) and to do this for approximately 3 s. 216 
Participants completed three MVCs with 30 s rest between each effort and the peak force was 217 
used for analysis. Intra-trial and inter-trial %CV was < 4%.    218 
Sprint time of a maximal effort 30 m sprint was recorded. The sprint was initiated from a line 219 
30 cm behind the start line to prevent false triggering of the timing gates (Brower telemetric 220 
timers, Brower timing systems, Draper, USA). Both intra-trial and inter-trial %CV was < 2%.   221 
Blood sampling and analysis 222 
Blood samples (10 mL) were collected via venepuncture from the antecubital fossa area into 223 
serum gel vacutainers. After allowing samples to rest at room temperature for a minimum of 224 
20 min, samples were centrifuged for 15 min (4°C) at 3000 RCF in order to obtain serum. 225 
The aliquots were stored at -80°C for later analysis of total CK. Due to difficulties with blood 226 
sampling, data for a single time point was missing out of a total of 100. Serum total CK 227 
concentrations were determined spectrophotometrically using an automated system (Roche 228 
Modular, Roche Diagnostics, Burgess Hill, UK). The inter-assay and intra-assay %CV were 229 
both < 2%.  230 
Statistical analysis 231 
To account for inter-individual variability, all dependant variables except for DOMS and CK 232 
are expressed as a percentage change relative to pre muscle damage values. Statistical 233 
software (IBM Statistical Package for Social Sciences (SPSS) V22 IBM, Armonk, USA) was 234 
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used for inferential analysis and statistical significance was accepted at the p ≤ 0.05 level a 235 
priori. Two-way group (2; WPH vs CHO) x time (5; pre, and 0, 24, 48 and 72 h post EIMD) 236 
repeated measures analysis of variance were performed for each dependent variable. 237 
Violations of assumptions were corrected and Least Significant Difference test (LSD) for 238 
adjustment for multiple comparisons was used to analyse significant main effects. 239 
Independent samples t tests were conducted on peak HR, peak RPE, fatigue, and total and 240 
mean sprint time to examine differences in exercise intensity during the repeated sprint 241 
protocol between groups. Where appropriate, Cohen’s D effect sizes (ES) were calculated 242 
with the magnitude of effects considered small (0.2), medium (0.5) and large (> 0.8). 243 
Results 244 
Independent samples t tests determined no differences between WPH and CHO groups for 245 
total sprint time, mean sprint time, fatigue, peak HR, and peak RPE during the repeated sprint 246 
protocol, thereby providing evidence that the exercise intensity was similar between groups. 247 
All dependent variable data not illustrated in figures are presented in Table 4. 248 
Delayed onset muscle soreness increased immediately post-exercise and remained elevated 249 
throughout recovery in both groups (p < 0.001), peaking at 48 h post-exercise; with no group 250 
differences or interaction effects. At all three locations (RF, VL and GM), there was a main 251 
effect of time for PPT percentage change (all p ≤ 0.001), which reached lowest levels at 24 h 252 
and then increased throughout recovery. There were no group differences and no interaction 253 
effects for PPT.  254 
Thigh and calf girths were unaffected post-exercise and there were no group differences or 255 
interaction effects. Flexibility was reduced throughout recovery (p < 0.001), with lowest 256 
levels observed at 48 h post-exercise in both groups (Figure 2), and no main effect of group 257 
(p = 0.104). However, there was an interaction effect (p = 0.050), where flexibility was 258 
 12 
improved beyond baseline measures at 72 h in the WPH group, but had failed to recover in 259 
the CHO group (p = 0.011, ES = 1.3).   260 
All measures of muscle function were reduced post-exercise and progressively recovered 261 
throughout recovery (p < 0.001 for CMJ, RSI and MVC; and p = 0.016 for 30 m sprint time). 262 
While recovery of these measures appeared to accelerate with WPH, a group effect was only 263 
evident with RSI (p = 0.016, ES = 0.6) (Figure 3).  264 
Both groups experienced an increase in circulating total CK (p < 0.001), which peaked 24 h 265 
post-exercise and remained elevated throughout recovery. There were no main effects of 266 
group (p = 0.408). However, there was an interaction effect (p = 0.002) and reductions in CK 267 
were greater following WPH consumption at 48 h compared to CHO (p = 0.031, ES= -1.1); 268 
where CK remained elevated throughout the 72 h recovery period (Figure 4). 269 
Discussion 270 
This investigation examined the effect of whey protein hydrolysate (WPH) supplementation 271 
on exercise recovery following EIMD in females. This study demonstrated for the first time 272 
that WPH reduces circulating CK, attenuates the decline in RSI, and accelerates recovery of 273 
hamstring flexibility compared to isocaloric CHO supplementation following repeated-sprint 274 
exercise in females.   275 
While not all measures improved, this study is in agreement with a number of investigations 276 
reporting accelerated recovery of muscle function following EIMD with ingestion of WPH 277 
(Buckley et al., 2010; Cooke et al., 2010; Hansen et al., 2015); although some have 278 
demonstrated no effect (Farup et al., 2014; Rahbek et al., 2015), or a detrimental effect (Lollo 279 
et al., 2014). Indeed, one study observed that isometric muscle force recovered beyond 280 
baseline values by 6 h post EIMD after a single 25 g dose of WPH, while it remained 281 
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suppressed with isoproteic whey protein isolate and non-caloric placebo supplementation 282 
(Buckley et al., 2010). The predominant mechanism thought to be responsible for the role of 283 
WPH in accelerating recovery is through the provision and increased availability of amino 284 
acids; vital for regeneration and/or de novo synthesis of protein and the repair of damaged 285 
contractile elements of the muscle fibres (Biolo, Tipton, Klein, & Wolfe, 1997). Indeed, 286 
though not directly measured in the present investigation, WPH supplementation may be 287 
superior compared to other forms of protein in this regard, as plasma concentrations of amino 288 
acids and dipeptides (and therefore their bioavailability) are greater following ingestion of 289 
protein hydrolysates compared to non-hydrolysed proteins (Koopman et al., 2009; Morifuji et 290 
al., 2010; Power, Hallihan, & Jakeman, 2009; Tang, Moore, Kujbida, Tarnopolsky, & 291 
Phillips, 2009). Importantly, while global MPS is increased with dietary protein intake, this 292 
includes an increase in myofibrillar protein synthesis observed at rest (Brodsky et al., 2004), 293 
and following resistance (Moore et al., 2009), endurance (Breen et al., 2011), concurrent 294 
(Camera et al., 2015), and repeated sprint cycling exercise (Coffey et al., 2011). An increase 295 
in myofibrillar protein synthesis with WPH ingestion may contribute to repair and 296 
remodeling of damaged myofibrils following EIMD. Perhaps a potential acceleration of 297 
myofibrillar repair may explain the observed improvement in hamstring flexibility and the 298 
reduction in CK at 48 h post EIMD with WPH supplementation reported in the present study.  299 
In addition, more compliant muscles are thought to be capable of storing more elastic energy 300 
(Brughelli & Cronin, 2007), therefore performance during activities utilising the stretch 301 
shortening cycle (such as drop jumps for measurement of RSI) might be improved. However, 302 
reductions in CK and improvements in flexibility were only evident at 48 h and 72 h post 303 
exercise, respectively; while reductions in RSI were attenuated throughout recovery. 304 
Notwithstanding, no other measures of muscle function were effected by WPH 305 
supplementation. Therefore, the role of accelerated myofibrillar repair in attenuating 306 
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increases in CK and reductions in RSI, and accelerating recovery of flexibility with WPH 307 
supplementation remains speculative and warrants further investigation.  308 
A strength of the present investigation was the dietary control employed throughout testing 309 
periods. The participants either achieved the recommended 1.2-1.7 g·kg-1·day-1 of protein 310 
(Tipton & Wolfe, 2004) (CHO group; 1.3 ± 0.2 g·kg-1·day-1) or a protein-rich diet (WPH 311 
group; 1.8 ± 0.2 g·kg-1·day-1). Some argue that as long as recommended levels of protein are 312 
achieved, further supplementation might be unnecessary in trained populations (Rennie & 313 
Tipton, 2000; Tipton, 2008). Despite this, a number of well-controlled studies have 314 
demonstrated that additional WPH (Hansen et al., 2015; Lollo et al., 2014) and BCAA 315 
(Coombes & McNaughton, 2000; Howatson et al., 2012; Jackman, Witard, Jeukendrup, & 316 
Tipton, 2010) supplementation is beneficial in attenuating EIMD, in spite of participants 317 
consuming recommended protein intakes. In the present investigation, since both groups were 318 
provided with sufficient intakes of macronutrients, and the daily diet and supplements were 319 
isocaloric, the attenuated reductions in muscle function and lower CK can be attributed to the 320 
additional protein provided by the WPH. Therefore, at least following strenuous exercise in 321 
females, this study lends support for the use of additional protein beyond recommended 322 
levels to reduce muscle damage and accelerate recovery. 323 
This study did not measure nitrogen balance, signaling enzymes associated with protein 324 
turnover, nor rates of MPS and MPB. Therefore, it was not possible to identify specific 325 
mechanisms which might have been responsible for the attenuated muscle damage response 326 
and accelerated recovery from EIMD with WPH compared with isocaloric CHO. Moreover, 327 
besides the provision of amino acids, there may be other mechanisms by which WPH 328 
influences recovery from EIMD. For instance, protein hydrolysate has been reported to 329 
exhibit antioxidant properties (Peng, Xiong, & Kong, 2009), which might contribute to 330 
reducing muscle damage by attenuating the oxidative stress response associated with 331 
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strenuous exercise. Moreover, WPH dipeptides have also been shown to increase glucose 332 
uptake in isolated skeletal muscle (Morifuji, Koga, Kawanaka, & Higuchi, 2009). While not 333 
measured in the present investigation, such effects of WPH might certainly have contributed 334 
to the present findings. The intervention in the present study also involved ingestion of WPH 335 
immediately post EIMD, and throughout the recovery period; therefore, it is difficult to 336 
identify whether ingestion close to the exercise bout is important. Interestingly, while RSI 337 
was significantly higher with WPH supplementation compared to an isocaloric CHO 338 
throughout recovery, the decline in RSI immediately post-exercise and ingestion of the first 339 
supplement was not different between groups (11.5 ± 12.4 and 18.8 ± 9.2% in WPH and 340 
CHO groups, respectively; independent t test; p = 0.155). In addition, the interaction effects 341 
observed in measures of CK and flexibility were evident at 48 h and 72 h post EIMD, 342 
respectively. Intuitively, for optimal recovery amino acids should be ingested both 343 
immediately post and in the days of recovery post-exercise where MPS is thought to persist 344 
(Miller et al., 2005; Phillips et al., 1997). However, the present study did not investigate the 345 
influence of supplementation timing and more research is warranted to establish optimal 346 
supplementation strategies.  347 
The main findings of this study were that four days of WPH supplementation improved 348 
recovery of muscle function (evidenced by improved RSI and flexibility) compared to 349 
isocaloric CHO supplementation, and that this was likely attributable to a reduction in muscle 350 
damage (evidenced by reduced CK). Though not directly measured, it is also likely that an 351 
increased delivery of amino acids with WPH supplementation was responsible for 352 
accelerating the repair of damaged skeletal muscle and thus its force generating capacity. 353 
While the observed improvements are arguably modest, acceleration in recovery of muscle 354 
function is of relevance to exercising females, and therefore is an important consequence of 355 
WPH supplementation. Indeed, these data support previous research demonstrating that 356 
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protein intakes beyond recommended levels can ameliorate recovery from EIMD. This 357 
research adds to the existing body of knowledge by demonstrating the application of WPH 358 
supplementation in female populations to improve recovery following strenuous exercise.  359 
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Figure captions 550 
Fig 1. Schematic of testing protocol illustrating time-points where the supplements were 551 
consumed and measures of dependent variables taken. Diet and exercise was controlled for 552 
24 h prior to exercise-induced muscle damage (EIMD) and for the duration of data collection.  553 
Fig 2. Hamstring stiffness and flexibility measured using the sit and reach test post exercise-554 
induced muscle damage in the whey protein hydrolysate (WPH) (n = 10) and carbohydrate 555 
(CHO) (n = 10) groups. Values presented as mean ± SD. #denotes significantly higher at 72 h 556 
in WPH group. Significance at p < 0.05. 557 
Fig 3. Reactive strength index (RSI) post exercise-induced muscle damage in the whey 558 
protein hydrolysate (WPH) (n = 10) and carbohydrate (CHO) (n = 10) groups. Values 559 
presented as mean ± SD. *denotes significantly higher RSI in WPH group. Significance at p < 560 
0.05. 561 
Fig 4. Total creatine kinase (CK) post exercise-induced muscle damage in the whey protein 562 
hydrolysate (WPH) (n = 10) and carbohydrate (CHO) (n = 10) groups. Values presented as 563 
mean ± SD. #denotes significantly greater reductions at 48 h in WPH group. Significance at  564 
p < 0.05.  565 
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Table 1. Standardised daily meal plan for participants over the four-day data collection 580 
period. 581 
Meal Food and drink provided 
Breakfast 2 x white bread, toasted, with butter and strawberry jam 
1 x glass of milk 
Lunch1 1 x sandwich or salad 
1 x packet of crisps 
1 x fruit smoothie 
Evening Meal1 1 x curry or chilli 
Snacks 1 x banana 
1 x cereal bar 
1 x packet of jelly sweets 
1 x yoghurt 
1The meals did not deviate from this standardised plan, however specific foods and flavours 582 
provided during lunch and the evening meal were altered each day to ensure a varied diet and 583 
to avoid monotony. 584 
  585 
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Table 2. Daily dietary intake of participants over the four-day data collection period1, mean ± 586 
SD. 587 
  Excluding Supplements Including Supplements 
Variable  WPH CHO WPH CHO 
Energy  kcal 2066 ± 108 2019 ± 183 2220 ± 108 2173 ± 183 
 MJ 8.6 ± 0.5 8.4 ± 0.8 9.3 ± 0.5 9.1 ± 0.8 
Carbohydrate g·kg-1 5.0 ± 0.7 5.5 ± 0.9 5.0 ± 0.7* 6.2 ± 1.0* 
 %TEI 61 ± 3 63 ± 2 58 ± 3* 66 ± 2* 
Protein  g·kg-1 1.2 ± 0.2 1.3 ± 0.2 1.8 ± 0.2* 1.3 ± 0.2* 
 %TEI 15 ± 1 15 ± 1 21 ± 1* 14 ± 1* 
Fat  g·kg-1 0.9 ± 0.1 0.9 ± 0.2 0.9 ± 0.1 0.9 ± 0.2 
 %TEI  25 ± 3 24 ± 1 23 ± 3 23 ± 1 
1As determined using dietary analysis software (Nutritics Ltd, Swords, Ireland). WPH, whey 588 
protein hydrolysate group (n = 10); CHO, carbohydrate group (n = 10); %TEI, percentage of 589 
total energy intake. *denotes significant difference between groups (p < 0.05). 590 
  591 
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Table 2. Daily dietary intake of participants over the four-day data collection period1, mean ± 592 
SD. 593 
  Excluding Supplements Including Supplements 
Variable  WPH CHO WPH CHO 
Energy  kcal 2066 ± 108 2019 ± 183 2220 ± 108 2173 ± 183 
 MJ 8.6 ± 0.5 8.4 ± 0.8 9.3 ± 0.5 9.1 ± 0.8 
Carbohydrate g·kg-1 5.0 ± 0.7 5.5 ± 0.9 5.0 ± 0.7* 6.2 ± 1.0* 
 %TEI 61 ± 3 63 ± 2 58 ± 3* 66 ± 2* 
Protein  g·kg-1 1.2 ± 0.2 1.3 ± 0.2 1.8 ± 0.2* 1.3 ± 0.2* 
 %TEI 15 ± 1 15 ± 1 21 ± 1* 14 ± 1* 
Fat  g·kg-1 0.9 ± 0.1 0.9 ± 0.2 0.9 ± 0.1 0.9 ± 0.2 
 %TEI  25 ± 3 24 ± 1 23 ± 3 23 ± 1 
1As determined using dietary analysis software (Nutritics Ltd, Swords, Ireland). WPH, whey 594 
protein hydrolysate group (n = 10); CHO, carbohydrate group (n = 10); %TEI, percentage of 595 
total energy intake. *denotes significant difference between groups (p < 0.05). 596 
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Table 4. Values for dependent variables in response to muscle-damaging exercise, mean ± SD. 597 
Variable Group 
Time post muscle-damaging exercise (h) 
Pre 0 24 48 72 
DOMS, mm WPH 0.0 ± 0.0 16.8 ± 19.9 ǂ 47.6 ± 26.7 ǂ 56.7 ± 17.8 ǂ 19.4 ± 13.2 ǂ 
 CHO 1.0 ± 2.5 13.0 ± 20.1 65.0 ± 49.0 ǂ 71.2 ± 45.0 ǂ 37.1 ± 27.4 ǂ 
RF PPT, % (N) WPH 100 ± 0 
(61.1 ± 18.2) 
102.5 ± 13.0 
(63.8 ± 25.0) 
89.9 ± 16.6 
(56.1 ± 23.7) 
98.9 ± 14.7 
(62.0 ± 24.8) 
120.5 ± 23.2 ǂ 
(75.3 ± 30.8) 
 CHO 100 ± 0 
(52.6 ± 14.7) 
102.3 ± 11.2 
(53.8 ± 15.3) 
97.4 ± 30.6 
(51.7 ± 23.8) 
104.1 ± 29.2 
(55.4 ± 23.0) 
123.4 ± 36.1 ǂ 
(65.6 ± 26.7) 
VL PPT, % (N) WPH 100 ± 0 
(61.0 ± 17.5) 
101.5 ± 12.0 
(61.9 ± 20.2) 
87.4 ± 15.7 
(53.9 ± 20.4) 
95.5 ± 20.7 
(59.1 ± 23.9) 
119.5 ± 18.2 ǂ 
(73.7 ± 26.8) 
 CHO 100 ± 0 
(50.9 ± 15.6) 
99.5 ± 12.5 
(50.3 ± 15.2) 
98.2 ± 25.9 
(48.7 ± 16.6) 
100.7 ± 33.0 
(50.9 ± 21.6) 
120.8 ± 37.2 
(60.8 ± 24.8) 
GM PPT, % (N) WPH 100 ± 0 101.1 ± 15.6 94.1 ± 16.6 106.9 ± 15.1 125.9 ± 22.5 ǂ 
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(60.6 ± 20.4) (61.1 ± 23.5) (57.2 ± 22.2) (64.1 ± 21.7) (74.2 ± 23.0) 
 CHO 100 ± 0 
(48.6 ± 17.8) 
97.3 ± 15.5 
(47.2 ± 17.5) 
94.6 ± 26.3 
(45.7 ± 21.0) 
101.9 ± 28.8 
(48.3 ± 17.8) 
116.0 ± 28.5 
(56.0 ±  24.4) 
Thigh girth, % (cm) 
 
 
WPH 100 ± 0 
(51.9 ± 4.4) 
100.3 ± 0.8 
(52.1 ± 4.4) 
100.1 ± 0.6 
(52.0 ± 4.3) 
99.8 ± 1.2 
(51.8 ± 4.0) 
99.7 ± 1.0 
(51.7 ± 4.2) 
CHO 100 ± 0 
(48.9 ± 3.5) 
99.9 ± 0.7 
(48.8 ± 3.3) 
100.2 ± 0.8 
(48.8 ± 3.2) 
100.2 ± 0.8 
(48.8 ± 3.2) 
100.6 ± 0.5 
(48.8 ± 3.3) 
Calf girth, % (cm) WPH 100 ± 0 
(36.9 ± 1.8) 
99.9 ± 0.4 
(36.8 ± 1.7) 
99.6 ± 0.5 
(36.7 ± 1.7) 
99.8 ± 0.6 
(36.8 ± 1.7) 
99.9 ± 0.8 
(36.8 ± 1.7) 
 
CHO 100 ± 0 
(35.0 ± 2.8) 
99.6 ± 0.5 
(34.9 ± 2.7) 
99.7 ± 1.1 
(34.9 ± 2.7) 
99.7 ± 0.6 
(34.9 ± 2.8) 
100.0 ± 0.9 
(35.0 ± 2.9) 
CMJ, % (cm) WPH 100 ± 0 
(26.8 ± 4.4) 
86.7 ± 8.4 ǂ 
(23.2 ± 4.5) 
94.2 ± 8.3 
(25.3 ± 5.5) 
92.2 ± 4.2 ǂ 
(24.6 ± 4.1) 
95.2 ± 7.1 
(25.6 ± 5.3) 
 CHO 100 ± 0 
(24.3 ± 2.8) 
88.1 ± 6.9 ǂ 
(21.3 ± 2.0) 
87.4 ± 10.0 ǂ 
(21.1 ± 2.6) 
89.7 ± 9.3 ǂ 
(21.7 ± 2.8) 
94.5 ± 11.1 
(22.9 ± 3.2) 
 34 
MVC, % (N)  WPH 100 ± 0 
(445.0 ± 69.9) 
91.6 ± 8.2 ǂ 
(409.4 ± 80.3) 
89.4 ± 10.3 ǂ 
(398.2 ± 75.1) 
89.5 ± 8.5 ǂ 
(399.8 ± 79.2) 
95.0 ± 9.9 
(423.7 ± 84.0) 
 CHO 100 ± 0 
(400.4 ± 66.6) 
84.6 ± 7.0 ǂ 
(399.2 ± 68.8) 
87.5 ± 9.2 ǂ 
(349.5 ± 61.2) 
88.1 ± 8.3 ǂ 
(353.2 ± 70.5) 
89.6 ± 11.5 ǂ 
(356.7 ± 62.9) 
30 m sprint time, % 
(s) 
WPH 100 ± 0 
(5.31 ± 0.34) 
102.7 ± 4.5 
(5.45 ± 0.38) 
101.8 ± 3.5 
(5.40 ± 0.37) 
101.2 ± 2.8 
(5.37 ± 0.38) 
99.7 ± 3.4 
(5.29 ± 0.36) 
 CHO 100 ± 0 
(5.36 ± 0.26) 
102.7 ± 4.7 
(5.50 ± 0.34) 
102.7 ± 4.4 ǂ 
(5.50 ± 0.30) 
100.6 ± 7.3 
(5.38 ± 0.38) 
100.7 ± 5.5 
(5.39 ± 0.30) 
WPH, whey protein hydrolysate group (n = 10); CHO, carbohydrate group (n = 10); %, % change from pre-exercise (Pre); DOMS, delayed onset 598 
muscle soreness; RF, rectus femoris; VL, vastus lateralis; GM, medial head of the gastrocnemius; PPT, pain pressure threshold; CMJ, 599 
countermovement jump; MVC, maximal voluntary isometric contraction. ǂdenotes significant difference from pre-exercise value (p < 0.05).  600 
 601 
